2021-03-26T13:40:52-05:00 2020-06-30 814234542 BPM LLP 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 940251021 990 2019-07-01 453266802 CANCER COMMONS CANC 6505303636 650 CASTRO STREET SUITE 120 PMB52 MOUNTAIN VIEW CA 94041 ERIKA MONTEVERDI EXECUTIVE DIRECTOR 6505303636 2021-03-10 1 TAMARA L MCINERNEY P00011797 6508556800 2021-03-10 2019 2022-09-23 18:48:47Z JAY M TENENBAUM 650 CASTRO STREET SUITE 120 PMB522 MOUNTAIN VIEW CA 94041 2104386 0 X WWW.CANCERCOMMONS.ORG X 2011 CA CANCER COMMONS BRINGS TOGETHER A TEAM OF EXPERTS, WHO COMBINE COMPASSION WITH SCIENTIFIC KNOWLEDGE TO HELP PATIENTS UNDERSTAND THEIR DISEASE AND ACCESS THEIR BEST TREATMENT OPTIONS. EACH PATIENT IS CONNECTED TO A TEAM, CONSISTING OF NURSE NAVIGATORS, PHD SCIENTISTS, PHYSICIANS, AND NATIONAL EXPERTS, WHO, REVIEW THE PATIENT'S MEDICAL HISTORY, RESEARCH ADDITIONAL TESTING THAT COULD IMPACT THE PATIENT'S TREATMENT PLAN, IDENTIFY CLINICAL TRIAL OPTIONS AVAILABLE FOR THE PATIENT, INVESTIGATE ACCESS TO NEW OFF-LABEL TREATMENTS, AS WELL AS OBTAIN KEY INSIGHTS FROM CANCER EXPERTS THROUGH VIRTUAL TUMOR BOARDS. CANCER COMMONS' GOAL IS TO EQUIP PATIENTS WITH THE KNOWLEDGE THEY NEED TO BE ABLE TO CHOOSE THEIR BEST PLAN OF ACTION AT NO COST TO THE PATIENT. 5 4 10 0 0 0 1802646 2103518 0 0 0 0 2500 868 1805146 2104386 0 0 0 0 786496 1109381 19000 0 194519 544267 820505 1349763 1929886 455383 174500 775135 883100 240242 173708 534893 709392 CANCER COMMONS BRINGS TOGETHER A TEAM OF EXPERTS, WHO COMBINE COMPASSION WITH SCIENTIFIC KNOWLEDGE TO HELP PATIENTS UNDERSTAND THEIR DISEASE AND ACCESS THEIR BEST TREATMENT OPTIONS. 0 0 1357218 SEE SCHEDULE O 174370 COVID 19. CANCER COMMONS WAS INVOLVED IN A RESEARCH STUDY CALLED "BEAT19" WHICH WAS DESIGNED TO HELP LEARN ABOUT WHAT HAPPENS BEFORE, DURING AND AFTER A PERSON HAS SYMPTOMS OF INFECTION BY SARS-COV-2, THE VIRUS THAT CAUSES COVID-19. SUPPORTED BY A $200,000 GRANT SEEKING TO UNDERSTAND THE IMPACT OF THE COVID 19 PANDEMIC ON CANCER PATIENTS AND THEIR CARE, CANCER COMMONS FOCUSED ON EACH PATIENT'S EXPERIENCE AND LEARNED THAT A SIGNIFICANT NUMBER HAVE FELT THEY WERE UNABLE TO ACCESS THE ADVANCED CARE THEY NEEDED. 1531588 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 24 0 10 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 4 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X MARTHA DEHNOW 6505303636 650 CASTRO STREET SUITE 120 PMB522 MOUNTAIN VIEW CA 94041 JAY M TENENBAUM CHAIR, DIRECTOR, PRESIDENT 20.00 X X 0 0 0 LAURENCE MARTON DIRECTOR 0.25 X 0 0 0 GLADYS MONROY DIRECTOR 0.50 X 0 0 0 EDWARD STAREN DIRECTOR 0.25 X 0 0 0 SHELLEY FRISBIE CFO 2.00 X X 16465 0 0 MASAKO YOKOTA SECRETARY 20.00 X 61457 0 34383 ERIKA MONTEVERDI EXECUTIVE DIRECTOR 40.00 X 171087 0 29617 EMILY SHTIVELMAN CHIEF SCIENTIST 33.00 X 140075 0 21605 389084 0 85605 2 0 1 0 0 200820 1902698 2103518 MISCELLANEOUS INCOME 900099 868 868 868 2104386 0 0 868 X 288607 241087 24335 23185 643256 551908 42807 48541 109945 70072 26355 13518 67573 59192 3921 4460 5308 5308 3675 3675 695368 534518 72619 88231 18158 9352 3412 5394 51350 26611 19467 5272 25950 16971 4537 4442 1623 1623 OTHER EXPENSES 19073 16569 1028 1476 1929886 1531588 203779 194519 557450 657483 155000 187500 30554 19265 32590 8612 5085 3954 3527 2000 2000 6912 0 775135 883100 108581 168528 131661 5180 240242 173708 X 14432 546140 520461 163252 534893 709392 775135 883100 174500 -1 0 X X 0 1 X 1 0 X 810884 1410505 1622936 1802396 2103518 7750239 810884 1410505 1622936 1802396 2103518 7750239 4423576 3326663 2500 868 3368 7753607 0.42900 0.41150 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8612 5085 3527 3527 PPP REFUNDABLE ADVANCE 5180 5180 X 2104386 0 2104386 0 2104386 1929886 0 1929886 0 1929886 PART X, LINE 2: ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA PROVIDE ACCOUNTING AND DISCLOSURE GUIDANCE ABOUT POSITIONS TAKEN BY AN ORGANIZATION IN ITS TAX RETURNS THAT MIGHT BE UNCERTAIN. MANAGEMENT HAS CONSIDERED ITS TAX POSITIONS AND BELIEVES THAT ALL OF THE POSITIONS TAKEN BY THE ORGANIZATION IN ITS FEDERAL AND STATE EXEMPT ORGANIZATION TAX RETURNS ARE MORE-LIKELY-THAN-NOT TO BE SUSTAINED UPON EXAMINATION. X 0 0 0 0 0 0 0 0 0 ERIKA MONTEVERDI EXECUTIVE DIRECTOR 171087 0 0 0 0 0 0 0 29617 0 200704 0 0 0 EMILY SHTIVELMAN CHIEF SCIENTIST 140075 0 0 0 0 0 21605 0 0 0 161680 0 0 0 FORM 990, PART III, LINE 4A PROVIDES A FREE, DIRECT TO PATIENT SERVICE THAT HELPS NAVIGATE CANCER TREATMENT OPTIONS AND OTHER ASPECTS OF THEIR CARE, WITH CONTINUED FOLLOW UP OVER TIME. ASSISTS PATIENTS WITH VARIOUS CANCER TYPES, PARTICULARLY THOSE THAT ARE DIFFICULT TO TREAT. THESE INCLUDE, BUT ARE NOT LIMITED TO, PANCREATIC, BRAIN, BREAST, LUNG, COLORECTAL, AND OVARIAN CANCERS. ACCOMPLISHMENTS ACROSS ALL CANCER TYPES INCLUDE: ENHANCED REGISTRATION PROCESS, WHICH INCLUDES A NURSE NAVIGATOR TO ASSIST PATIENT AND CAREGIVERS COLLECT MEDICAL RECORDS AND IDENTIFY THEIR SPECIFIC NEEDS INCLUDING GOALS OF TREATMENT. CREATION OF A LIBRARY OF "TREATMENT OPTIONS" FOR CANCER PATIENTS, BY CANCER TYPE, BASED ON THE LATEST CLINICAL AND SCIENTIFIC DISCOVERIES. FORMED VIRTUAL TUMOR BOARDS (VTB), A NETWORK OF NATIONAL EXPERTS INCLUDING ONCOLOGISTS, RADIATION ONCOLOGISTS, SURGEONS, AND CLINICAL SCIENTISTS, ORGANIZED BY CANCER TYPE. THESE VTBS REVIEW INDIVIDUAL CANCER PATIENTS' CASES AND PROVIDE BEST IN CLASS, DETAILED TREATMENT OPTIONS REPORTS TO SHARE WITH THE PATIENTS' ONCOLOGISTS AND MEDICAL TEAMS. ABILITY FOR PATIENTS CAN ENROLL IN A "PERPETUAL CLINICAL TRIAL". PERPETUAL TRIALS ARE OPEN TO PATIENTS RECEIVING CARE IN THE U.S. AND ALLOWS THE ORGANIZATION TO LEARN FROM EACH PATIENT IN ORDER TO HELP SIMILAR PATIENTS, AND EVENTUALLY, ALL FUTURE PATIENTS. SERVICES WERE PROVIDED TO 624 NEW CANCER PATIENTS DURING THE YEAR ENDED JUNE,30, 2020. CANCER COMMONS' TEAM MEMBERS ENGAGED THESE AND HUNDREDS OF OTHER PATIENTS IN OVER 11,000 INTERACTIONS (EMAILS AND PHONE CALLS). FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS GIVEN TO THE GOVERNING BODY BEFORE THE RETURN IS FILED. THEY REVIEW AND CAN REQUEST CHANGES AT THIS TIME. FORM 990, PART VI, SECTION B, LINE 12C THE OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE REQUIRED TO REVIEW AND SIGN THE WRITTEN CONFLICT OF INTEREST POLICY ANNUALLY. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF DIRECTORS PERFORMS ALL INTERVIEWS SPECIFIC TO TOP KEY POSITIONS WHICH IS THEN FORWARDED TO THE FULL BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. FORM 990, PART VI, SECTION C, LINE 19 MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G IT CONSULTING: PROGRAM SERVICE EXPENSES 2,800. MANAGEMENT AND GENERAL EXPENSES 2,981. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 5,781. OUTSIDE CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 531,718. MANAGEMENT AND GENERAL EXPENSES 69,638. FUNDRAISING EXPENSES 88,231. TOTAL EXPENSES 689,587. FORM 990, PART XII, LINE 2C THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.